Cartesian Therapeutics Inc (RNAC)
R&D Expense Growth
4.97%
Quarterly · Period ending:
RNAC R&D Expense Growth
Latest reported4.97%period ending
Latest reported4.97%period ending
RNAC Quarterly R&D Growth (QoQ) (0.00% → 4.97%)
Latest values, visible window
High-resolution chart · PNG
RNAC r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 4.9735% | |
| 32.5005% | |
| 6.4266% | |
| -7.176% | |
| 1.3289% | |
| 29.7895% | |
| -0.8246% | |
| -9.9597% | |
| 30.0164% | |
| -56.5869% | |
| 72.5196% | |
| -26.8811% | |
| -4.521% | |
| -1.8084% | |
| 14.6805% | |
| -13.7785% | |
| 8.4403% | |
| -12.9393% | |
| -3.0213% | |
| 44.8593% | |
| 11.2196% | |
| -13.8294% | |
| 8.1017% | |
| 30.1025% | |
| -27.1258% | |
| -2.8247% | |
| 86.9694% | |
| -33.2125% | |
| 65.0211% | |
| -28.3054% | |
| -13.7064% | |
| -17.5054% | |
| 29.3384% | |
| -18.2339% | |
| 43.3396% | |
| -13.5528% | |
| -0.4527% | |
| 0.0997% | |
| 83.242% | |
| 0.35% | |
| -9.7473% | |
| -7.8075% | |
| 31.5156% | |
| 3.1803% | |
| 6.8785% | |
| 0% |